Arrhythmia-related workup in hereditary myopathies

Journal of Electrocardiology

Volumn 45, Issue 4, 2012, Pages 376-384

  Finsterer, Josef ^a,b   Stöllberger, Claudia ^a   Keller, Hans ^a  

^a KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

^b DANUBE UNIVERSITY KREMS   (Austria)

Author keywords

Arrhythmias; Cardiac conduction defects; ECG recording; Electrocardiogram; Heart rhythm; Holter; Impulse generation or propagation defects; Loop recorder

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ASYSTOLE; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; CENTRONUCLEAR MYOPATHY; DANON DISEASE; DEFIBRILLATOR; DYSTROPHINOPATHY; EMERY DREIFUSS MUSCULAR DYSTROPHY; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FATTY ACID OXIDATION; FOLLOW UP; FUKUYAMA CONGENITAL MUSCULAR DYSTROPHY; GENETIC DISORDER; GLYCOGEN STORAGE DISEASE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE FAILURE; HEART PREEXCITATION; HEART SINOATRIAL BLOCK; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE FLUTTER; HEART VENTRICLE TACHYCARDIA; HEREDITARY MUSCLE DISEASE; HUMAN; HYPOKALEMIC PERIODIC PARALYSIS; LAMINOPATHY; LEBER HEREDITARY OPTIC NEUROPATHY; MCLEOD SYNDROME; MELAS SYNDROME; MITOCHONDRIAL MYOPATHY; MUSCLE EYE BRAIN DISEASE; MYOPATHY; MYOTONIC DYSTROPHY; PRIORITY JOURNAL; QT PROLONGATION; REVIEW; SICK SINUS SYNDROME; SINUS ARREST; SINUS BRADYCARDIA; SINUS TACHYCARDIA; SUDDEN DEATH; SUPRAVENTRICULAR TACHYCARDIA; SYNCOPE; SYSTEMATIC REVIEW; THOMSEN DISEASE; WALKER WARBURG SYNDROME; WOLFF PARKINSON WHITE SYNDROME;

ARRHYTHMIAS, CARDIAC; HEART CONDUCTION SYSTEM; HUMANS; MUSCULAR DISEASES; RISK FACTORS;

EID: 84862875343     PISSN: 00220736     EISSN: 15328430     Source Type: Journal    
DOI: 10.1016/j.jelectrocard.2012.02.003     Document Type: Review

References (51)

1. Finsterer J, Ramaciotti C, Wang CH, et al. Cardiac findings in congenital muscular dystrophies. Pediatrics 2010;126:538.
2. Hsu DT. Cardiac manifestations of neuromuscular disorders in children. Paediatr Respir Rev 2010;11:35.
3. Babuty D, Lallemand B, Laurent V, et al. When do you implant a pacemaker in myotonic dystrophy? Presse Med 2011 (in press).
4. Sovari AA, Dudley Jr SC. Sudden death in myotonic dystrophy. N Engl J Med 2008;359:1628.
5. Lazarus A, Varin J, Jauvert G, Alonso C, Duboc D. Relationship between cardiac arrhythmias and sleep apnoea in permanently paced patients with type I myotonic dystrophy. Neuromuscul Disord 2007;17:392.
6. Sovari AA, Bodine CK, Farokhi F. Cardiovascular manifestations of myotonic dystrophy-1. Cardiol Rev 2007;15:191.
7. Anguera I, Nicolàs J, Sabaté X, Esplugas E. Syncopal ventricular tachycardia as the first manifestation of Steinert's disease. Rev Esp Cardiol 2010;63:112.
8. Shibata J, Fujisawa T, Shimizu S, et al. Case of myotonic dystrophy with pulmonary atelectasis and torsade de pointes in the perioperative period. Masui 2008;57:1253.
9. Rakocević-Stojanović V, Pavlović S, Lavrnić D, Apostolski S. Frequency of electrocardiographic changes in patients with myotonic dystrophy. Srp Arh Celok Lek 1995;123:247.
10. Breton R, Mathieu J. Usefulness of clinical and electrocardiographic data for predicting adverse cardiac events in patients with myotonic dystrophy. Can J Cardiol 2009;25:e23.
11. Groh WJ, Groh MR, Saha C, et al. Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. N Engl J Med 2008;358:2688.
12. Wahbi K, Meune C, Bécane HM, et al. Left ventricular dysfunction and cardiac arrhythmias are frequent in type 2 myotonic dystrophy: a case control study. Neuromuscul Disord 2009;19:468.
13. Brembilla-Perrot B, Luporsi JD, Louis S, Kaminsky P. Long-term follow-up of patients with myotonic dystrophy: an electrocardiogram every year is not necessary. Europace 2011;13:251.
14. Kaminsky P, Brembilla-Perrot B, Pruna L, Poussel M, Chenuel B. Age, conduction defects and restrictive lung disease independently predict cardiac events and death in myotonic dystrophy. Int J Cardiol 2011 (in press).
15. Cudia P, Bernasconi P, Chiodelli R, et al. Risk of arrhythmia in type I myotonic dystrophy: the role of clinical and genetic variables. J Neurol Neurosurg Psychiatry 2009;80:790.
16. Romfh A, McNally EM. Cardiac assessment in Duchenne and Becker muscular dystrophies. Curr Heart Fail Rep 2010;7:212.
17. Ammendola E, Russo V, Politano L, Santangelo L, Calabrò R. Is heart rate variability a valid parameter to predict sudden death in patients with Becker's muscular dystrophy? Heart 2006;92:1686.
18. Yilmazer MM, Omeroǧlu RE, Bornaun H, Oner N, Nişli K, Ertuǧrul T. Repolarization abnormalities in Duchenne-type muscular dystrophy. Turk Kardiyol Dern Ars 2009;37:538.
19. Corrado G, Lissoni A, Beretta S, et al. Prognostic value of electrocardiograms, ventricular late potentials, ventricular arrhythmias, and left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy. Am J Cardiol 2002;89:838.
20. Yotsukura M, Yamamoto A, Kajiwara T, et al. QT dispersion in patients with Duchenne-type progressive muscular dystrophy. Am Heart J 1999;137:672.
21. Matsumura T, Tamura T, Kuru S, Kikuchi Y, Kawai M. Carvedilol can prevent cardiac events in Duchenne muscular dystrophy. Intern Med 2010;49:1357.
22. Duboc D, Meune C, Pierre B, et al. Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years' follow-up. Am Heart J 2007;154:596.
23. Worman HJ, Bonne G. "Laminopathies": a wide spectrum of human diseases. Exp Cell Res 2007;313:2121.
24. Ishikawa K, Mimuro M, Tanaka T. Ventricular arrhythmia in X-linked Emery-Dreifuss muscular dystrophy: a lesson from an autopsy case. Intern Med 2011;50:459.
25. Meune C, Van Berlo JH, Anselme F, Bonne G, Pinto YM, Duboc D. Primary prevention of sudden death in patients with lamin A/C gene mutations. N Engl J Med 2006;354:209.
26. Charniot JC, Desnos M, Zerhouni K, et al. Severe dilated cardiomyopathy and quadriceps myopathy due to lamin A/C gene mutation: a phenotypic study. Eur J Heart Fail 2006;8:249.
27. van Berlo JH, de Voogt WG, van der Kooi AJ, et al. Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death? J Mol Med 2005;83:79.
28. van Tintelen JP, Tio RA, Kerstjens-Frederikse WS, et al. Severe myocardial fibrosis caused by a deletion of the 5′ end of the lamin A/C gene. J Am Coll Cardiol 2007;49:2430.
29. Boriani G, Gallina M, Merlini L, et al. Clinical relevance of atrial fibrillation/flutter, stroke, pacemaker implant, and heart failure in Emery-Dreifuss muscular dystrophy: a long-term longitudinal study. Stroke 2003;34:901.
30. Nigro G, Russo V, Ventriglia VM, et al. Early onset of cardiomyopathy and primary prevention of sudden death in X-linked Emery-Dreifuss muscular dystrophy. Neuromuscul Disord 2010;20:174.
31. Wortmann SB, Rodenburg RJ, Backx AP, Schmitt E, Smeitink JA, Morava E. Early cardiac involvement in children carrying the A3243G mtDNA mutation. Acta Paediatr 2007;96:450.
32. Welzing L, von Kleist-Retzow JC, Kribs A, Eifinger F, Huenseler C, Sreeram N. Rapid development of life-threatening complete atrio-ventricular block in Kearns-Sayre syndrome. Eur J Pediatr 2009;168:757.
33. Sproule DM, Kaufmann P, Engelstad K, Starc TJ, Hordof AJ, De Vivo DC. Wolff-Parkinson-White syndrome in Patients With MELAS. Arch Neurol 2007;64:1625.
34. Vydt TC, de Coo RF, Soliman OI, et al. Cardiac involvement in adults with m.3243A>G MELAS gene mutation. Am J Cardiol 2007;99:264.
35. Khatami M, Houshmand M, Sadeghizadeh M, et al. Accumulation of mitochondrial genome variations in Persian LQTS patients: a possible risk factor? Cardiovasc Pathol 2010;19:e21.
36. Wahbi K, Larue S, Jardel C, et al. Cardiac involvement is frequent in patients with the m.8344A>G mutation of mitochondrial DNA. Neurology 2010;74:674.
37. Zhang LH, Fang LG, Cheng ZW, Fang Q. Cardiac manifestations of patients with mitochondrial disease. Zhonghua Xin Xue Guan Bing Za Zhi 2009;37:892.
38. Limongelli G, Tome-Esteban M, Dejthevaporn C, Rahman S, Hanna MG, Elliott PM. Prevalence and natural history of heart disease in adults with primary mitochondrial respiratory chain disease. Eur J Heart Fail 2010;12:114.
39. Yahyaoui R, Espinosa MG, Gómez C, et al. Neonatal carnitine palmitoyltransferase II deficiency associated with Dandy-Walker syndrome and sudden death. Mol Genet Metab 2011 (in press).
40. Bonnefont JP, Djouadi F, Prip-Buus C, Gobin S, Munnich A, Bastin J. Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects. Mol Aspects Med 2004;25:495.
41. Wasant P, Matsumoto I, Naylor E, Liammongkolkul S. Mitochondrial fatty acid oxidation disorders in Thai infants: a report of 3 cases. J Med Assoc Thai 2002;85(suppl 2):S710.
42. Wood JC, Magera MJ, Rinaldo P, Seashore MR, Strauss AW, Friedman A. Diagnosis of very long chain acyl-dehydrogenase deficiency from an infant's newborn screening card. Pediatrics 2001; 108:E19.
43. Bonnet D, Martin D, De Lonlay P, et al. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children. Circulation 1999;100:2248.
44. Saudubray JM, Martin D, de Lonlay P, et al. Recognition and management of fatty acid oxidation defects: a series of 107 patients. J Inherit Metab Dis 1999;22:488.
45. Sanderson JE, Lai KB, Shum IO, Wei S, Chow LT. Transforming growth factor-beta(1) expression in dilated cardiomyopathy. Heart 2001;86:701.
46. Groh WJ. Sudden death in myotonic dystrophy. N Engl J Med 2008;359:1626.
47. Zipes DP, Camm AJ, Borggrefe M, et al American College of Cardiology/American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006;114:e385.
48. Asbach S, Gutleben KJ, Dahlem P, Brachmann J, Nölker G. Myotonic dystrophy initially presenting as tachycardiomyopathy successful catheter ablation of atrial flutter. Cardiol Res Pract 2010:2010.
49. Fauchier L, Babuty D, Pellieux S, Toutain A, Cosnay P. Conduction defects and arrhythmias in peripheral myopathies. Arch Mal Coeur Vaiss 2004;4:25.
50. Lazarus A, Varin J, Babuty D, Anselme F, Coste J, Duboc D. Long-term follow-up of arrhythmias in patients with myotonic dystrophy treated by pacing: a multicenter diagnostic pacemaker study. J Am Coll Cardiol 2002;40:1645.
51. Pelargonio G, Dello Russo A, Sanna T, De Martino G, Bellocci F. Myotonic dystrophy and the heart. Heart 2002;88:665.